You are here: All Products  > Celest Therapeutics Acquires Novel CAR-NK Cell Therapy from Senti Bio in $156 Million Deal

Celest Therapeutics Acquires Novel CAR-NK Cell Therapy from Senti Bio in $156 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products